Harnessing Deubiquitinases for Next-Generation Protein Stability Therapeutics
Originally recorded October 6, 2023
Sara Buhrlage, PhD
Dana-Farber Cancer Institute
Harvard Medical School
Originally recorded October 6, 2023
Dana-Farber Cancer Institute
Harvard Medical School